Page last updated: 2024-08-24

liarozole and Psoriasis

liarozole has been researched along with Psoriasis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (50.00)18.2507
2000's2 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Decree, J; Degreef, H; Dockx, P1
Bergers, M; Boegheim, PJ; Den Bakker, JE; Kuijpers, AL; Schalkwijk, J; Siegenthaler, G; Van de Kerkhof, PC; Van Pelt, JP1
Berth-Jones, J; Hutchinson, PE; Thestrup-Pedersen, K; Todd, G; Vanhoutte, FP1
Bhushan, M; Burden, AD; Griffiths, CE; James, R; McElhone, K; Vanhoutte, FP1

Trials

4 trial(s) available for liarozole and Psoriasis

ArticleYear
Inhibition of the metabolism of endogenous retinoic acid as treatment for severe psoriasis: an open study with oral liarozole.
    The British journal of dermatology, 1995, Volume: 133, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Antimetabolites; Arthritis, Psoriatic; Female; Humans; Imidazoles; Male; Middle Aged; Psoriasis; Severity of Illness Index; Treatment Outcome; Tretinoin

1995
The effects of oral liarozole on epidermal proliferation and differentiation in severe plaque psoriasis are comparable with those of acitretin.
    The British journal of dermatology, 1998, Volume: 139, Issue:3

    Topics: Acitretin; Administration, Oral; Adult; Aged; Cell Differentiation; Cell Division; Double-Blind Method; Epidermis; Female; Humans; Imidazoles; Immunoenzyme Techniques; Keratolytic Agents; Leukocyte Count; Male; Middle Aged; Proteinase Inhibitory Proteins, Secretory; Proteins; Psoriasis; Serine Proteinase Inhibitors

1998
Treatment of psoriasis with oral liarozole: a dose-ranging study.
    The British journal of dermatology, 2000, Volume: 143, Issue:6

    Topics: Administration, Oral; Adolescent; Adult; Aged; Dermatologic Agents; Dose-Response Relationship, Drug; Female; Humans; Imidazoles; Male; Middle Aged; Psoriasis; Treatment Outcome

2000
Oral liarozole in the treatment of palmoplantar pustular psoriasis: a randomized, double-blind, placebo-controlled study.
    The British journal of dermatology, 2001, Volume: 145, Issue:4

    Topics: Administration, Oral; Adolescent; Adult; Aged; Dermatologic Agents; Double-Blind Method; Female; Follow-Up Studies; Humans; Imidazoles; Male; Middle Aged; Psoriasis; Severity of Illness Index; Treatment Outcome

2001